BRIDGEWAY CAPITAL MANAGEMENT, LLC - GEMPHIRE THERAPEUTICS INC ownership

GEMPHIRE THERAPEUTICS INC's ticker is GEMP and the CUSIP is 36870A108. A total of 25 filers reported holding GEMPHIRE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of GEMPHIRE THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$9,000
-55.0%
25,0000.0%0.00%
Q2 2019$20,000
-31.0%
25,0000.0%0.00%
Q1 2019$29,000
-95.3%
25,000
-58.3%
0.00%
-100.0%
Q2 2018$611,000
+56.3%
60,0000.0%0.01%
+50.0%
Q1 2018$391,000
-18.0%
60,0000.0%0.00%
-20.0%
Q4 2017$477,00060,0000.01%
Other shareholders

There were no reported owners of GEMPHIRE THERAPEUTICS INC in Q1 2019.

NameSharesValueWeighting ↓
View complete list of GEMPHIRE THERAPEUTICS INC shareholders